← Human Trials & Peer-Reviewed Studies
Effect of Multi-Ingredient Supplement Containing Satiereal, Naringin, and Vitamin D on Body Composition, Mood, and Satiety in Overweight Adults.
Plain-language guide to PMID 29336628 (2018): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement).
Key Facts
- PMID
- 29336628
- Journal
- Journal of dietary supplements
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Gonzalez AM et al. (6 authors)
- DOI
- 10.1080/19390211.2017.1407385
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc and Copper (Supplement).
The purpose of this investigation was to examine the effects of 28 days of a dietary supplement on body composition, mood, and satiety in overweight adults.
Why It Was Studied
Twenty healthy adults (25.5 ± 3.8 years; 87.3 ± 20.7 kg; 169.9 ± 10.6 cm; 29.9 ± 5.1 body mass index) participated in this randomized, double-blind, placebo-controlled investigation.
Baseline (PRE) and post (POST) assessments included body mass, BMI, and waist circumference measures.
Who Took Part
The age groups tagged for this paper are adults.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
Neither the participants nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
What Was Measured
Baseline (PRE) and post (POST) assessments included body mass, BMI, and waist circumference measures.
Topics PubMed links to this paper include Affect, Body Composition, Body Mass Index, Cholecalciferol, Dietary Supplements, Energy Intake and Exercise.
Author keywords: appetite, obesity, satiety and weight loss.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement).
The publication is from 2018 (Journal of dietary supplements), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page and the Copper (Supplement) compound page, all human trials.
Our Notes on the Compounds
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.